These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Urgent treatment of patients with metastatic melanoma using Braf inhibitors in the absence of Braf mutation status. Nathan P; Sharma A; Lorigan P Ann Oncol; 2013 Jun; 24(6):1712-3. PubMed ID: 23613475 [No Abstract] [Full Text] [Related]
6. BRAF inhibitors: research accelerates in wake of positive findings. Brower V J Natl Cancer Inst; 2010 Feb; 102(4):214-5. PubMed ID: 20145213 [No Abstract] [Full Text] [Related]
7. Eruptive squamous cell carcinomas associated with BRAF-inhibitor therapy in a patient with metastatic melanoma. Ezra N; Hamid O; Behroozan D Dermatol Surg; 2012 Jul; 38(7 Pt 1):1086-90. PubMed ID: 22563699 [No Abstract] [Full Text] [Related]
8. [Selective blockade of the mutated BRAF leads to a survival benefit in patients with metastatic melanoma]. Schadendorf D J Dtsch Dermatol Ges; 2011 Apr; 9(4):340. PubMed ID: 21439018 [No Abstract] [Full Text] [Related]
9. BRAF mutation analysis of only one metastatic lesion can restrict the treatment of melanoma: a case report. Richtig E; Schrama D; Ugurel S; Fried I; Niederkorn A; Massone C; Becker JC Br J Dermatol; 2013 Feb; 168(2):428-30. PubMed ID: 22775439 [No Abstract] [Full Text] [Related]
11. [Gene abnormalities in melanoma and signal transduction antagonists]. Takada M Gan To Kagaku Ryoho; 2013 Apr; 40(4):453-7. PubMed ID: 23894754 [No Abstract] [Full Text] [Related]
12. Vemurafenib therapy for stage IV melanoma with V600G-mutation. Lang N; Weisser A; Enk A; Hassel JC J Dtsch Dermatol Ges; 2013 Dec; 11(12):1198-9. PubMed ID: 24016000 [No Abstract] [Full Text] [Related]
13. Rapidly metastasizing malignant melanoma characterized by a rare BRAF mutation not responding to vemurafenib. Starz H; Gutschi M; Welzel J; Haas C J Dtsch Dermatol Ges; 2014 Feb; 12(2):151-4. PubMed ID: 24238398 [No Abstract] [Full Text] [Related]
14. What, if Any, Role Is There for BRAF-Targeted Therapy in Sullivan RJ J Clin Oncol; 2022 Dec; 40(36):4161-4165. PubMed ID: 35862870 [No Abstract] [Full Text] [Related]
15. Selumetinib increases the efficacy of first-line dacarbazine. Cancer Discov; 2013 Jul; 3(7):OF16. PubMed ID: 23847359 [TBL] [Abstract][Full Text] [Related]
16. The role of triple therapy in BRAF-positive melanoma. Sullivan RJ Clin Adv Hematol Oncol; 2022 Jun; 20(6):359-361. PubMed ID: 35731606 [No Abstract] [Full Text] [Related]
17. Is it good or bad to find a BRAF mutation? Flaherty KT J Clin Oncol; 2011 Apr; 29(10):1229-30. PubMed ID: 21343552 [No Abstract] [Full Text] [Related]